Skip to main content
Log in

Gray Platelet Syndrome with Severe Thrombocytopenia: A Novel NBEAL2 Gene Variant from India

  • Correspondence
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Availablity of data and material

Patient data is available on request from corresponding author.

References

  1. Nurden AT, Nurden P (2020) Inherited thrombocytopenias: history, advances and perspectives. Haematologica 105(8):2004–2019. https://doi.org/10.3324/haematol.2019.233197

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Glembotsky AC, De Luca G, Heller PG (2021) A deep dive into the pathology of gray platelet syndrome: new insights on immune dysregulation. J Blood Med 12:719–732. https://doi.org/10.2147/JBM.S270018

    Article  PubMed  PubMed Central  Google Scholar 

  3. Pluthero FG, Di Paola J, Carcao MD, Kahr WHA (2018) NBEAL2 mutations and bleeding in patients with gray platelet syndrome. Platelets 29(6):632–635. https://doi.org/10.1080/09537104.2018.1478405

    Article  CAS  PubMed  Google Scholar 

  4. Bottega R, Pecci A, De Candia E et al (2013) Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency. Haematologica 98(6):868–874. https://doi.org/10.3324/haematol.2012.075861

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Shahraki H, Dorgalaleh A, Bain BJ (2018) Gray platelet syndrome (GPS). In: Dorgalaleh A, (ed) Congenital bleeding disorders. Springer, Cham. doi: https://doi.org/10.1007/978

Download references

Acknowledgements

The authors extend their sincere thanks to Dr. Michele P. Lambert, Medical Director ­ Special Coagulation Laboratory, Associate Professor ­ Department of Pediatrics, Attending Physician—Division of Hematology Children's Hospital of Philadelphia, USA for sharing her expertise.

Funding

None to declare.

Author information

Authors and Affiliations

Authors

Contributions

VMG: Conceptualization, Methodology, Formal analysis, Investigation, Manuscript editing and Manuscript review. AMV: Methodology, Literature search, Investigation, Manuscript preparation and Manuscript review. KV: Methodology, Manuscript preparation, Formal analysis, Manuscript editing and Manuscript review. VBK, SLKL, SB: Methodology, Formal analysis, Manuscript editing and Manuscript review.

Corresponding author

Correspondence to Vishwapriya Mahadev Godkhindi.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical Approval

In accordance with ethical standards of the institutional ethics committee & with the 1964 Helsinki declaration and its later amendments or comparable national/international guidelines.

Informed Consent

Written informed consent was obtained from all the participants in the study.

Code Availablity

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mevalegire Venkatagiri, A., Vijayasekharan, K., Bhat, K.V. et al. Gray Platelet Syndrome with Severe Thrombocytopenia: A Novel NBEAL2 Gene Variant from India. Indian J Hematol Blood Transfus 38, 754–756 (2022). https://doi.org/10.1007/s12288-022-01531-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-022-01531-3

Navigation